Influence of amiodarone on spectral analysis of heart rate variability in patients with atrial fibrillation (clinical observation)
https://doi.org/10.33667/2078-5631-2019-2-30(405)-18-22
Abstract
Spectral analysis of heart rate variability can be successfully used to evaluate the effectiveness of therapy. The use of this method gives an idea of the role of the autonomic nervous system in the regulation of chronotropic function of the heart. These data help to define conditions of manifestation of efficiency of antiarrhythmic drugs. In this study, spectral analysis were studied in patients with persistent atrial fibrillation. The effect of amiodarone class III antiarrhythmic drug were studied this study.
About the Authors
E. P. Popova
First Moscow State Medical University n. a. I. M. Sechenov
Russian Federation
Moscow
Russian Federation
Moscow
O. T. Bogova
Russian Medical Academy for Postgraduate Continuous Education
Russian Federation
Moscow
Russian Federation
Moscow
S. N. Puzin
First Moscow State Medical University n. a. I. M. Sechenov; Russian Medical Academy for Postgraduate Continuous Education; Federal Research Clinical Center for Resuscitation and Rehabilitation, Lytkino, Moscow Region
Russian Federation
Russian Federation
Moscow
D. A. Sychyov
Russian Medical Academy for Postgraduate Continuous Education
Russian Federation
Moscow
Russian Federation
Moscow
V. P. Fisenko
First Moscow State Medical University n. a. I. M. Sechenov
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Баевский Р. М., Иванов И. И., Чирейкин Л. В. и др. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем (методические рекомендации) // Вестник аритмологии. 2001. № 24. С. 65–87.
2. Баевский Р. М., Кириллов О. И., Клецкин С. З. Математический анализ изменений сердечного ритма при стрессе // М. Наука. 1984.
3. Искендеров Б. Г., Рахматуллов Ф. К. Структурные и электрофизиологические показатели функции сердца при пароксизмальной мерцательной аритмии // Терапевтический архив. 2001. № 12. С. 52–56.
4. Кринский В. И., Михайлов А. С. Автоволны // М. Знание. 1984.
5. Флейшман А. Н., Филимонов С. Н., Климина Н. В. Новый способ подбора препаратов для лечения артериальной гипертонии на основе спектрального анализа вариабельности ритма сердца // Терапевтический архив. 2001. № 12. С. 33–39.
6. Явелов И. С., Грацианский Н. А., Зуйков Ю. А. Вариабельность ритма сердца при острых коронарных синдромах: значение для оценки прогноза заболевания. Обзор // Кардиология. 1997. № 2. С. 61–69.
7. Akselrod S., Eds M. Malik, Camm A. J. Components of heart rate variability. Basis studies. In: Heart Rate Variability // Armonk. N. Y. Futura Pablishity. Comp. Inc. 1995. Р. 147–163.
8. Akselrod S., Gordon D., Madwed J. B. Hemodynamic regulation: Investigation by spectral analysis // Am. J. Physiol. 1985. Vol. 249. P. 867–875.
9. Gal P., Elvan A., Rossi P. Effect of parasympathetic nerve stimulation on atrial and atrioventricular nodal electrophysiological characteristics // Int. J. Cardiol. 2016. Vol. 205. P. 83–85.
10. Hanley C. M., Robinson V. M., Peter R., Kowey P. R. Status of Antiarrhythmic Drug Development for Atrial Fibrillation. New Drugs and New Molecular Mechanisms // Circ. Arrhythm Electrophysiol. 2016. Vol. 9, N 3. P. 1–9.
11. Hohendanner F., Heinzel F. R., Blaschke F. Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure // Heart Fail Rev. 2018. Vol. 23, N 1. P. 27–36.
12. Jaïs P., Haïssaguerre M., Shah D. C. A focal source of atrial fibrillation treated by discrete radiofrequency ablation // Circulation. 1997. Vol. 95, N 3. P. 572–576.
13. Kirchhof P. A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network // European Heart Rhythm Association consensus conference. Europace. 2016. Vol. 18, N 1. P. 37–50.
14. Lok N. S., Lau C. P. Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fibrillation // Pacing Clin. Electrophysiol. 1998. Vol. 21, N 2. P. 386–395.
15. Patel P. A., Ali N., Hogarth A. Management strategies for atrial fibrillation // J. R. Soc. Med. 2017. Vol. 110, N 1. P. 13–22.
16. Task Forse of the European Society of Cardiology and the North American Society of Paciety of Pacing and Electrophysiology. Heart rate variability. Standarts of measurements, physiological interpretation and clinical use. // Circulation. 1996. Vol., N 93. P. 1043–1065.
17. Wang Z., Page P., Nattel S. Mechanism of flecainide’s antiarrhythmic action in experimental atrial fibrillation // Circ. Res. 1992. Vol. 71, N 2. P. 271–287.
Review
For citations:
Popova E.P., Bogova O.T., Puzin S.N., Sychyov D.A., Fisenko V.P. Influence of amiodarone on spectral analysis of heart rate variability in patients with atrial fibrillation (clinical observation). Medical alphabet. 2019;2(30):18-22. (In Russ.) https://doi.org/10.33667/2078-5631-2019-2-30(405)-18-22
Views:
638
Email this article 